In this study, FASN expression was not correlated with prognostic markers, such as OS or DFS, or pathological features, such as nodal metastasis, TNM stage, histological grade, ER status, PR status, and Ki-67 index, of breast cancer patients. This evidence concerns the gene PGR and breast cancer.